Page last updated: 2024-08-18

pyrazolanthrone and bosutinib

pyrazolanthrone has been researched along with bosutinib in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	1 (50.00)	2.80

Authors

Authors	Studies
Caballero, E; García-Cárceles, J; Gil, C; Martínez, A	1
Dong, Q; Ge, J; Huang, Q; Tian, S; Zhao, L; Zhu, H	1

Reviews

1 review(s) available for pyrazolanthrone and bosutinib

Article	Year
Kinase Inhibitors as Underexplored Antiviral Agents. Journal of medicinal chemistry, 2022, 01-27, Volume: 65, Issue:2 Topics: Animals; Antiviral Agents; Drug Repositioning; Humans; Protein Kinase Inhibitors; Virus Diseases; Viruses	2022

Other Studies

1 other study(ies) available for pyrazolanthrone and bosutinib

Article	Year
Integrative identification of unexpected kinase-inhibitor interactions in the MAPK-mediated proliferation and differentiation of Mc3T3-E1 osteoblasts. General physiology and biophysics, 2019, Volume: 38, Issue:1 Topics: Aniline Compounds; Animals; Anthracenes; Cell Differentiation; Cell Line; Cell Proliferation; Dasatinib; Imidazoles; MAP Kinase Signaling System; Mice; Mitogen-Activated Protein Kinase Kinases; Nitriles; Osteoblasts; Protein Kinase Inhibitors; Pyridines; Pyrimidines; Quinolines	2019

Article

Year

Integrative identification of unexpected kinase-inhibitor interactions in the MAPK-mediated proliferation and differentiation of Mc3T3-E1 osteoblasts.

General physiology and biophysics, 2019, Volume: 38, Issue:1

Topics: Aniline Compounds; Animals; Anthracenes; Cell Differentiation; Cell Line; Cell Proliferation; Dasatinib; Imidazoles; MAP Kinase Signaling System; Mice; Mitogen-Activated Protein Kinase Kinases; Nitriles; Osteoblasts; Protein Kinase Inhibitors; Pyridines; Pyrimidines; Quinolines

2019